| P50 | author | Gary S Mintz | Q96436990 |
| | Enrico Romagnoli | Q43632188 |
| | Francesco Burzotta | Q57007938 |
| | Francesco Saia | Q57078794 |
| P2093 | author name string | Luca Di Vito | |
| | Francesco Prati | |
| | Fausto Castriota | |
| | Laura Gatto | |
| | Valeria Marco | |
| | Alessio La Manna | |
| | Nevio Taglieri | |
| | Vito Ramazzotti | |
| | Francesco Amico | |
| | Alberto Boi | |
| | Alessandro Di Giorgio | |
| | Marco Contarini | |
| P2860 | cites work | Universal definition of myocardial infarction: Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction | Q22242900 |
| | Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents | Q28174787 |
| | Correlation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosis | Q28252547 |
| | Stent thrombosis in randomized clinical trials of drug-eluting stents | Q28287921 |
| | Clinical end points in coronary stent trials: a case for standardized definitions | Q36807166 |
| | Late stent malapposition risk is higher after drug-eluting stent compared with bare-metal stent implantation and associates with late stent thrombosis | Q37374015 |
| | Pathology of second-generation everolimus-eluting stents versus first-generation sirolimus- and paclitaxel-eluting stents in humans | Q37561357 |
| | Expert review document on methodology, terminology, and clinical applications of optical coherence tomography: physical principles, methodology of image acquisition, and clinical application for assessment of coronary arteries and atherosclerosis | Q37628295 |
| | Mechanisms, pathophysiology, and clinical aspects of incomplete stent apposition | Q38188329 |
| | Fixed and Modifiable Correlates of Drug-Eluting Stent Thrombosis From a Large All-Comers Registry: Insights From ADAPT-DES. | Q38402937 |
| | Delayed coverage in malapposed and side-branch struts with respect to well-apposed struts in drug-eluting stents: in vivo assessment with optical coherence tomography | Q38487718 |
| | Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes | Q38497485 |
| | Clinical Impact of OCT Findings During PCI: The CLI-OPCI II Study. | Q41127319 |
| | Vascular tissue reaction to acute malapposition in human coronary arteries: sequential assessment with optical coherence tomography | Q44188416 |
| | Randomized comparison of acute stent malapposition between platinum-chromium versus cobalt-chromium everolimus-eluting stents. | Q44745465 |
| | Optical coherence tomography versus intravascular ultrasound to evaluate coronary artery disease and percutaneous coronary intervention. | Q45782647 |
| | From bench to bedside: a novel technique of acquiring OCT images | Q46622942 |
| | Frequency-domain optical coherence tomography findings in patients with bifurcated lesions undergoing provisional stenting | Q46800270 |
| | The influence of strut thickness and cell design on immediate apposition of drug-eluting stents assessed by optical coherence tomography | Q47360559 |
| | Mechanisms of Very Late Drug-Eluting Stent Thrombosis Assessed by Optical Coherence Tomography | Q48884077 |
| | Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents | Q50176817 |
| | Assessment of coronary arterial thrombus by optical coherence tomography. | Q50732372 |
| | Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. | Q51170005 |
| | Examination of the in vivo mechanisms of late drug-eluting stent thrombosis: findings from optical coherence tomography and intravascular ultrasound imaging. | Q51454257 |
| | Angiographic predictors of 2-year stent thrombosis in patients receiving drug-eluting stents: Insights from the ADAPT-DES study. | Q51545745 |
| | Mechanisms of stent thrombosis analysed by optical coherence tomography: insights from the national PESTO French registry. | Q51565382 |
| | Outcomes of everolimus-eluting stent incomplete stent apposition: a serial optical coherence tomography analysis. | Q51777056 |
| | Incomplete stent apposition causes high shear flow disturbances and delay in neointimal coverage as a function of strut to wall detachment distance: implications for the management of incomplete stent apposition. | Q53595568 |
| | Incidences, predictors, and clinical outcomes of acute and late stent malapposition detected by optical coherence tomography after drug-eluting stent implantation. | Q53639109 |
| | Impact of incomplete stent apposition on long-term clinical outcome after drug-eluting stent implantation | Q57643930 |
| P433 | issue | 4 | |
| P304 | page(s) | 566-575 | |
| P577 | publication date | 2017-03-15 | |
| P1433 | published in | Catheterization and Cardiovascular Interventions | Q2352240 |
| P1476 | title | Role of residual acute stent malapposition in percutaneous coronary interventions | |
| P478 | volume | 90 | |